The Medical Device Epidemiology - Real World Data Sciences (MD EPI-RWDS) organization in Johnson & Johnson conducts observational research to support product development, product launch, post-market safety and effectiveness, value assessments, and business development of medical devices. The team leads RWD innovation and methodological excellence across Johnson & Johnson’s medical device sector. The team provides skills in using real-world evidence to answer questions related to epidemiology of the indication, safety, product development, label extensions, value demonstration for payers, and other activities.
The research associate will partner with MD Operating Companies to formulate and address research questions related to orthopedic devices using a variety of analytical techniques applied to various databases. The person will be responsible for assisting with various projects and initiatives in areas of epidemiology, health economics, outcomes research, and post-market safety surveillance. Examples of specific activities will include managing projects, drafting protocols and analyzing electronic healthcare databases (insurance claims data, hospital billing data, EMRs, registries, etc.) to evaluate disease natural history, safety and effectiveness of treatments using clinical and surrogate endpoints, or benefit-risk questions for specific devices.
KEY JOB RESPONSIBILITIES
The role will involve participation in various project teams and task forces in addressing issues raised by product teams or regulatory agencies, where it will provide epidemiologic, predictive analytic and/or health economic consulting to product teams, generate needed real-world evidence, and/or disseminate scientific information through technical reports or models, presentations, and publications in peer-reviewed literature, as agreed by the team.
Close collaboration with cross-functional teams involving R&D leaders, data scientists, healthcare researchers and healthcare providers is a key requirement of this position.
This position will also be responsible for the following:
Participating in various work streams/ task forces to standardize research and analytical processes to improve efficiency and quality of deliverables
Facilitating access to key healthcare databases and providing core analytics capability for clinicians and researchers across the sector;
Supporting the Post-market Surveillance Initiative to enhance safety and surveillance activities as part of product life cycle management
EDUCATION / EXPERIENCE
A minimum of a PhD in biostatistics, health services research, epidemiology, health policy, health outcomes research or other related field is required.
Knowledge of healthcare databases, economic and predictive modeling, and other related analytical methodology is required.
The candidate must have a sophisticated understanding and the ability to analyze and interpret quantitative data using statistical software such as SAS, R, etc.
Experience with writing methods sections of study proposals/ protocols/ or background epidemiologic material on specific disease or therapeutic areas is a must.
The incumbent must have strong written and verbal communication skill.
WORK ENVIRONMENT: Office.
TRAVEL REQUIREMENTS: Overnight travel may be required up to 10%
LOCATION: New Brunswick, NJ prerferred. Other locations with remote work environment will be strongly considered.
Internal Number: RAAug2019
About Johnson and Johnson
Johnson & Johnson, incorporated on November 10, 1887, is a holding company. The Company and its subsidiaries are engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates through three segments: Consumer, Pharmaceutical and Medical Devices. The Company's primary focus is on products related to human health and well-being. The Company's subsidiaries operated 119 manufacturing facilities, as of January 1, 2017. The Company's research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom. The Company has over 230 operating companies, which conduct business around the world.